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Purpose.To investigate the role of systemic arterial stiffness in glaucomapatientswith diabetesmellitus (DM).Design.Retrospective,
cross-sectional study. Participants. DM subjects who underwent brachial-ankle pulse wave velocity (baPWV) were recruited.
Methods. Glaucoma patients (𝑛 = 75) and age-matched control subjects (𝑛 = 92) were enrolled. Systemic examination including
BaPWV and detailed eye examination were performed. The glaucoma group was divided into subgroups of normal tension
glaucoma (NTG, 𝑛 = 55) and primary open-angle glaucoma (POAG) based on an IOP of 21mmHg. BaPWV was used to stratify
the population into 4 groups based on the rate. Stepwise multiple logistic regression analysis by baPWV quartiles was used to
compare the glaucoma group with the control group. Main Outcome Measures. BaPWV in glaucoma with DM patients. Results.
Faster baPWV was positively associated with glaucoma (odds ratio: 3.74; 95% CI: 1.03–13.56, stepwise multiple logistic regression
analysis) in patients with DM. Increasing baPWV was also positively associated with glaucoma (𝑝 for trend = 0.036). The NTG
subgroup showed similar results to those of the glaucoma group. Conclusions. In this study, increased arterial stiffness was shown
to be associated with glaucoma and may contribute to the pathogenesis of glaucoma in DM patients.
1. Introduction
Glaucoma is defined as chronic progressive optic nerve dam-
age and regarded as amultifactorial disease caused by genetic,
local, systemic, and environmental factors [1].The traditional
theoretical mechanisms of the development of glaucoma
include the mechanical theory, which emphasizes the role of
high intraocular pressure (IOP) [2], and the ischemic theory,
which focuses on disturbance of blood flow [3]. Recently,
many studies have demonstrated systemic risk factors for
glaucoma, like metabolic syndrome [4], helicobacter pylori
[5], diabetes mellitus (DM) [6], and thyroid disease [7].
The Beaver Dam eye study [6], national health care study
[8], and meta-analysis study [9, 10] have suggested that DM
is significantly associated with increased IOP and glaucoma.
Thus, this is an area of ongoing investigation and debate.
Another possibility is that glaucoma may be associated not
just with DM but also with its secondary effect on systemic
or local factors. The hypothetical mechanisms of DM as a
risk factor for glaucoma include the alteration of biochemical
pathways, increased oxidative stress by lipid metabolism, and
blood flow alteration by the disturbance of autoregulation of
vascular endothelium [11].
Some studies about migraine [12], peripheral blood flow
[13], or systemic blood flow [14] have suggested that the
disturbance of systemic circulation is a possible risk factor
for glaucoma. Increased arterial stiffness, which can occur
as a consequence of arteriosclerosis, is associated with DM
and systemic hypertension, which may in part explain the
increased cardiovascular disease risk observed in these con-
ditions. However, there are few studies on the association
between glaucoma and arterial stiffness and its potential
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impact on retinal circulation. Furthermore, the relationship
between systemic circulation abnormalities such as DM,
systemic hypertension, and glaucoma remains unclear.
In this study, we evaluated the role of systemic arterial
stiffness in DM patients with glaucoma.
2. Materials and Methods
This study was a retrospective chart review. Subjects were
recruited from the glaucoma outpatient clinic at Kangbuk
Samsung Hospital, Seoul, Korea, from January to December
2013. All subjects were new patients who were referred from
or subjects who were followed in the DM clinic of the same
hospital. This study was performed in accordance with the
Declaration of Helsinki andwas approved by the Institutional
Review Board and ethics committee of Kangbuk Samsung
Hospital in Seoul, Korea.
For inclusion in this study, all participants met the
following criteria: the logarithm of the minimal angle of
resolution best corrected visual acuity (logMAR BCVA) was
0.70 or better, a spherical equivalent within 6 diopters (D)
and a cylinder within 3D, the presence of an open-angle
on gonioscopic examination, and reliable VF test results.
Glaucoma was diagnosed by a glaucoma specialist using the
following criteria: presence of typical glaucomatous optic
disc neuropathy including rim thinning or notching in the
inferior or superior temporal area of the optic nerve head,
corresponding glaucomatous VF loss including paracentral,
arcuate scotomas, or a nasal step [15], and no apparent
secondary cause of glaucomatous optic neuropathy. Deter-
mination of the diurnal IOP consisted of measuring the IOP
every 150 minutes from 9 a.m. to 5 p.m. at the first visit in the
absence of glaucoma medications. Based on this diurnal IOP
profile, we divided the glaucoma group into normal tension
glaucoma (NTG, less than 21mmHg peak IOP) and primary
open-angle glaucoma (POAG).
Exclusion criteria were active ocular disease, proliferative
diabetic retinopathy (PDR) in any eye, use of other ocu-
lar medications or therapies that might have a substantial
effect on IOP, and history of ocular surgery. After detailed
ophthalmic evaluation including fundus exam after pupil
dilation, the right eye was chosen for inclusion in cases in
which both eyes of the patient were eligible for the study. For
the control group (patients without glaucoma), age-matched
subjects were selected.
All subjects underwent a detailed ophthalmic exam-
ination including medical and ophthalmic histories, best
corrected visual acuity (BCVA) testing, IOP measurements
by Goldmann applanation tonometry, VF testing (Zeiss-
Humphrey, San Leandro, CA), color disc photography (Visu-
cam Pro NM model; Carl Zeiss Meditec, Inc.), and optical
coherence tomography (Cirrus OCT, Carl Zeiss Meditec,
Inc., Dublin, CA). Systemic examinations were performed
including measurements of brachial-ankle pulse wave veloc-
ity (baPWV) (automatic waveform analyzer: VP-1000, Colin
Co., Komaki, Japan) for assessment of systemic arterial stiff-
ness. This instrument records baPWV (cm/sec), electrocar-
diogram, systemic blood pressure (BP), pulse pressure (PP),
and ankle-brachial index (ABI). The baPWV was measured
after the subject was allowed to rest for at least 5 minutes.
Carotid intima-media thickness (IMT) was also measured
at the common carotid artery, bulb, and internal carotid
artery with carotid sonography (Vivid E9, GE Healthcare,
WI, USA). Body mass index (BMI) was calculated as weight
in kilograms divided by the height in meters squared. Lab-
oratory blood tests including total cholesterol, triglyceride
(TG), and fasting blood glucose (FBS) were performed. And
hemoglobin A1c (HbA1C) were performed as index which
represent severity of DM.
2.1. Statistical Methods. Baseline demographic information
and clinical parameters were compared between groups using
independent sample 𝑡-tests or one-way analysis of variance
(ANOVA) with the Bonferroni post hoc test for continuous
variables and Chi-square tests or Fisher’s exact tests for
categorical variables.
Odds ratios (OR) with 95% confidence intervals (95%
CI) were estimated using logistic regression models. BaPWV
was stratified into 4 groups based on the rate. Following
univariate analyses, multivariate logistic regression analyses
were performed to identify independent risk factors for
glaucoma using backward selection based on the likelihood
ratio.
All data were analyzed using SPSS statistical software
system version 21.0 (IBM SPSS, Inc., Chicago, Illinois, USA).
A 𝑝 value < 0.05 was considered to be statistically significant.
3. Results
A total of 167 patients were enrolled in the study, 108 of whom
were men and 59 of whom were women. The mean age was
59.26 ± 9.86 years (range, 34–79 years). Sixty-nine patients
(41.3%) had hypertension.
Table 1 shows the demographics and clinical data of
subjects. All subjects were divided into the glaucoma group
(𝑛 = 75) or the control group (𝑛 = 92). There was no signif-
icant difference in demographics and clinical characteristics
between the glaucoma and control groups. Mean baPWV of
the glaucoma group was about 88.3 cm/sec (5.7%) faster than
that of the control group (1638.73 ± 276.04 versus 1550.43 ±
256.39, independent sample 𝑡-tests, 𝑝 = 0.035) Right baPWV
of the glaucoma group was about 83.9 cm/sec (5.4%) faster
than that of the control group (1633.16 ± 278.05 versus
1549.24 ± 260.54, independent sample 𝑡-tests, 𝑝 = 0.048).
Left baPWV of the glaucoma group was about 92.7 cm/sec
(6.0%) faster than that of the control group (1644.31±280.46
versus 1551.63 ± 258.36, independent sample 𝑡-tests, 𝑝 =
0.029). There were not any significant differences in mean
IOP, systolic and diastolic BP, PP, mean arterial pressure, ABI,
IMT, BMI, total cholesterol, TG or FBS, and HbA1C between
the glaucoma and control groups. Six patients (8.0%) have
mild nonproliferative diabetic retinopathy (NPDR) in OAG
group and 5 patients (5.4%) in control group. And moderate
NPDR showed in 4 patients (5.3%) in OAG and 2 patients
(2.2%) in control group. Severe NPDR showed in 2 patients
(2.7% in OAG, 2.2% control group) in each group. There was
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Table 1: Comparison of demographic and clinical data.
OAG (𝑛 = 75) Control (𝑛 = 92) 𝑝 value
Gender (male : female) 47 : 28 61 : 31 0.625
Mean age (years) 59.03 ± 10.15 59.46 ± 9.68 0.78
Hypertension 29 (38.7%) 40 (43.5%) 0.53
Mean IOP (mmHg) 14.55 ± 4.08 13.93 ± 2.85 0.26
Systolic blood pressure (mmHg) 126.80 ± 18.10 125.28 ± 13.77 0.54
Diastolic blood pressure (mmHg) 75.87 ± 9.98 74.87 ± 9.53 0.51
Pulse pressure (mmHg) 50.93 ± 12.63 50.41 ± 9.38 0.76
Mean arterial pressure (mmHg) 93.56 ± 11.83 91.67 ± 10.21 0.30
Mean baPWV (cm/s) 1638.73 ± 276.04 1550.43 ± 256.39 0.035
baPWV, Rt. (cm/s) 1633.16 ± 278.05 1549.24 ± 260.54 0.048
baPWV, Lt. (cm/s) 1644.31 ± 280.46 1551.63 ± 258.36 0.029
ABI, Rt. 1.14 ± 0.08 1.12 ± 0.11 0.26
ABI, Lt. 1.14 ± 0.09 1.12 ± 0.10 0.21
Intima-media thickness (IMT)
CCA, Rt. (mm) 0.71 ± 0.13 0.68 ± 0.14 0.28
CCA, Lt. (mm) 0.71 ± 0.16 0.73 ± 0.15 0.53
Bulb, Rt. (mm) 0.86 ± 0.23 0.83 ± 0.17 0.43
Bulb, Lt. (mm) 0.80 ± 0.18 0.86 ± 0.23 0.21
ICA, Rt. (mm) 0.56 ± 0.13 0.55 ± 0.08 0.58
ICA, Lt. (mm) 0.54 ± 0.07 0.57 ± 0.08 0.20
Body mass index (BMI) 25.80 ± 6.08 25.19 ± 3.46 0.44
Total cholesterol 169.04 ± 41.72 161.08 ± 39.14 0.21
Triglyceride 179.37 ± 2266.87 141.02 ± 167.58 0.28
Fast blood glucose 145.47 ± 55.84 133.59 ± 43.33 0.12
HbA1C (%) 6.97 ± 1.23 7.00 ± 1.32 0.87
Diabetic retinopathy 0.639
No diabetic retinopathy 63 (84.0%) 83 (90.2%)
Mild NPDR 6 (8.0%) 5 (5.4%)
Moderate NPDR 4 (5.3%) 2 (2.2%)
Severe NPDR 2 (2.7%) 2 (2.2%)
Data are expressed as the mean ± standard deviation (SD) or frequency (%).
baPWV: brachial-ankle pulse wave velocity; ABI: ankle-brachial index; CCA: common carotid artery; ICA: internal carotid artery; NPDR: nonproliferative
diabetic retinopathy.
no statistically significant difference of severity of diabetic
retinopathy between the glaucoma and control groups.
Comparing of demographic and clinical data in NTG,
POAG and control group showed in Table 2. There was no
significant difference in systolic and diastolic BP, PP, mean
arterial pressure, ABI, IMT, BMI, total cholesterol, TG or
FBS, andHbA1C between the NTG and POAG groups except
mean IOP. In comparison of baPWVamong the three groups,
mean baPWV of the NTG group was about 112.8 cm/sec
(7.3%) faster than that of the control group (1663.25 ± 287.35
versus 1550.43 ± 256.39, independent sample 𝑡-tests, 𝑝 =
0.02). However, mean baPWV of the POAG group was about
only 20.9 cm/sec (1.3%) faster than that of the control group
(1571.33 ± 235.76 versus 1550.43 ± 256.39, independent
sample 𝑡-tests, 𝑝 = 0.04).
Stepwisemultiple logistic regression analysiswas adjusted
for age, gender, mean arterial BP, BMI, TG, HbA1C, and
severity of diabetic retinopathy; it showed that a faster than
1740.5 cm/sec (fourth quartile) (OR adjusted for age, gender,
mean arterial BP, BMI, TG, HbA1C, and severity of diabetic
retinopathy: 3.74; 95% CI: 1.03–13.56, Table 3) was indepen-
dently associated with glaucoma. Furthermore, increasing
baPWV was an independent risk factor of glaucoma (𝑝 for
trend = 0.036).
In subgroup analyses, the NTG group comprised 55
patients. The results were similar to the total analysis
(Table 4). Stepwise multiple logistic regression model, the
fourth quartile (baPWV above 1718 cm/sec) (OR adjusted for
age, gender, mean arterial BP, BMI, TG, HbA1C, and sever-
ity of diabetic retinopathy: 4.26; 95% CI: 1.08–16.88) were
independently associated with NTG (Table 4). Furthermore,
increasing baPWV was an independent risk factor of NTG
(𝑝 for trend = 0.025). There was no independently associated
factor with POAG (Table 5).
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Table 2: Comparison of demographic and clinical data in NTG, POAG, and control group.
NTG (𝑛 = 55) POAG (𝑛 = 20) Control (𝑛 = 92) 𝑝 value
Gender (male : female) 35 : 20 12 : 8 61 : 31 0.85
Mean age (years) 60.02 ± 56.30 56.30 ± 10.91 59.46 ± 9.68 0.34
Hypertension 22 (40.0%) 7 (35.0%) 40 (43.5%) 0.76
Mean IOP (mmHg) 13.15 ± 2.64 18.38 ± 4.90 13.93 ± 2.85 <0.001
Systolic blood pressure (mmHg) 126.91 ± 18.50 126.50 ± 17.41 125.28 ± 13.77 0.83
Diastolic blood pressure (mmHg) 75.09 ± 9.56 78.00 ± 11.04 74.87 ± 9.53 0.42
Pulse pressure (mmHg) 51.82 ± 12.95 48.50 ± 11.68 50.41 ± 9.38 0.49
Mean arterial pressure (mmHg) 92.36 ± 11.73 99.03 ± 11.16 91.67 ± 10.21 0.09
Mean baPWV (cm/s)∗ 1663.25 ± 287.35 1571.33 ± 235.76 1550.43 ± 256.39 0.04
baPWV, Rt. (cm/s) 1659.27 ± 291.81 1561.35 ± 227.36 1549.24 ± 260.54 0.052
baPWV, Lt. (cm/s)∗ 1667.22 ± 288.66 1581.30 ± 252.65 1551.63 ± 258.36 0.042
ABI, Rt. 1.13 ± 0.08 1.16 ± 0.07 1.12 ± 0.11 0.23
ABI, Lt. 1.13 ± 0.09 1.16 ± 0.08 1.12 ± 0.10 0.17
Intima-media thickness (IMT)
CCA, Rt. (mm) 0.72 ± 0.13 0.65 ± 0.08 0.68 ± 0.14 0.27
CCA, Lt. (mm) 0.72 ± 0.17 0.65 ± 0.11 0.73 ± 0.15 0.49
Bulb, Rt. (mm) 0.88 ± 0.25 0.74 ± 0.06 0.83 ± 0.17 0.18
Bulb, Lt. (mm) 0.81 ± 0.19 0.74 ± 0.11 0.86 ± 0.23 0.37
ICA, Rt. (mm) 0.56 ± 0.13 0.57 ± 0.10 0.55 ± 0.08 0.84
ICA, Lt. (mm) 0.55 ± 0.07 0.52 ± 0.06 0.57 ± 0.08 0.33
Body mass index (BMI) 26.09 ± 6.90 25.02 ± 2.81 25.19 ± 3.46 0.50
Total cholesterol 164.80 ± 41.23 180.70 ± 41.88 161.08 ± 39.14 0.14
Triglyceride 174.93 ± 287.37 191.60 ± 206.09 141.02 ± 167.58 0.51
Fast blood glucose 148.02 ± 61.13 138.45 ± 38.10 133.59 ± 43.33 0.23
HbA1C (%) 7.08 ± 1.33 6.67 ± 0.86 7.00 ± 1.32 0.47
Diabetic retinopathy 0.39
No diabetic retinopathy 46 (83.6%) 17 (85.0%) 83 (90.2%)
Mild NPDR 3 (5.5%) 3 (15.0%) 5 (5.4%)
Moderate NPDR 4 (7.3%) 0 (0%) 2 (2.2%)
Severe NPDR 2 (3.6%) 0 (0%) 2 (2.2%)
Data are expressed as the mean ± standard deviation (SD) or frequency (%).
baPWV: brachial-ankle pulse wave velocity; ABI: ankle-brachial index; CCA: common carotid artery; ICA: internal carotid artery; NPDR: nonproliferative
diabetic retinopathy. ∗𝑝 < 0.05 between NTG and control.
4. Discussion
Our study showed that high baPWV was an independent
risk factor for glaucoma in DM patients. Moreover, faster
baPWV was positively associated with increasing OR of
glaucoma. These findings suggest that arterial stiffness may
be an independent risk factor for glaucoma. baPWV is a good
surrogate measure of the effect of systemic arterial stiffness
on ocular blood vessels, which may estimate ocular blood
flow. In subgroup analysis, the NTG group showed similar
results. Mrocxkowska et al. suggested that NTG and POAG
patients showed similarly increased nocturnal systemic blood
pressure variability (𝑝 = 0.01), peripheral arterial stiffness
(𝑝 = 0.02), carotid intima-media thickness (𝑝 = 0.04),
and reduced ocular perfusion pressure (𝑝 < 0.001). Their
study showed that POAG and NTG patients exhibit similar
alterations in ocular and systemic circulation in the early
stages of their disease process [16]. Arterial stiffness may lead
to the disruption of ocular autoregulation [17]. In this study,
there was no significantly different clinical data including
baPWV between the NTG and POAG groups except mean
IOP. Mean baPWV of the NTG group was about 7.3% faster
than that of the control group. However, mean baPWV of
the POAG group was about only 1.3% faster than that of the
control group.These results suggested that arterial stiffness is
more associated with NTG than with POAG.
PWV was known as a good marker of systemic arterial
stiffness as it reflects local as well as systemic circulation [18,
19]. Furthermore, the baPWV measurement unit was tech-
nically simple and could be used to check the status of both
the central arteries and peripheral arteries. A previous study
found that baPWV had good validity and reproducibility for
assessing vascular damage [20]. Although baPWVwas a good
marker of systemic arterial stiffness, the results can still be
affected by age [17], gender [17], BP [21], BMI [17], and plasma
triglycerides [17]. To rule out the effect of BP variation,
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Table 3: Multivariate logistic regression analysis by quartile baPWV.
Risk factor Odds ratio 95% confidence interval 𝑝 value
Age 0.98 0.94 1.02 0.30
Gender
Female 1
Male 1.03 0.48 2.20 0.94
Mean arterial pressure 0.99 0.96 1.03 0.62
Body mass index 1.03 0.96 1.12 0.40
Triglyceride 1.00 0.999 1.002 0.36
HbA1C 1.00 0.77 1.31 0.98
Diabetic retinopathy
No diabetic retinopathy (𝑛 = 63) 1
Mild NPDR (𝑛 = 6) 1.32 0.35 4.97 0.69
Moderate NPDR (𝑛 = 4) 2.55 0.43 15.24 0.31
Severe NPDR (𝑛 = 2) 1.28 0.17 9.88 0.81
baPWV (cm/s)∗
baPWV ≤ 1390 (𝑛 = 14) 1
1390 < baPWV ≤ 1549.5 (𝑛 = 17) 1.79 0.64 5.05 0.27
1549.5 < baPWV ≤ 1740.5 (𝑛 = 21) 3.07 0.98 9.63 0.054
1740.5 < baPWV (𝑛 = 23) 3.74 1.03 13.56 0.045
∗
𝑝 for trend = 0.036.
Table 4: Multivariate logistic regression analysis by quartile baPWV in NTG.
Risk factor Odds ratio 95% confidence interval 𝑝 value
Age 0.98 0.94 1.03 0.36
Gender
Female 1
Male 1.06 0.47 2.37 0.89
Mean arterial pressure 0.98 0.94 1.02 0.30
Body mass index 1.03 0.96 1.12 0.42
Triglyceride 1.00 0.999 1.002 0.47
HbA1C 1.02 0.78 1.34 0.90
Diabetic retinopathy
No diabetic retinopathy (𝑛 = 46) 1
Mild NPDR (𝑛 = 3) 1.01 0.22 4.61 1.00
Moderate NPDR (𝑛 = 4) 2.76 0.45 16.99 0.27
Severe NPDR (𝑛 = 2) 1.57 0.20 12.40 0.67
baPWV (cm/s)∗
baPWV ≤ 1389.5 (𝑛 = 10) 1
1389.5 < baPWV ≤ 1549.5 (𝑛 = 11) 1.56 0.51 4.79 0.44
1549.5 < baPWV ≤ 1718 (𝑛 = 16) 3.24 0.95 11.03 0.06
1718 < baPWV (𝑛 = 18) 4.26 1.08 16.88 0.039
∗
𝑝 for trend = 0.025.
baPWVwas checked routinely in the resting state after at least
10 minutes of break in all subjects. In addition, we adjusted
our results for age, gender, BP, BMI, and plasma triglycerides
to exclude confounding factors. In our study, there were no
significant associations between HTN, SBP, DBP, PP, ABI,
IMT, BMI, total cholesterol level, triglyceride level, FBS,
HbA1C, severity of diabetic retinopathy, and glaucoma. The
severity of DM complications of our subjects was no more
than severe NPDR, which suggests that lack of evident sys-
temic complications may be an important factor. Severity of
diabetic retinopathy was not different between glaucoma and
control group. Furthermore,HbA1Cdid not show statistically
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Table 5: Multivariate logistic regression analysis by quartile baPWV in POAG.
Risk factor Odds ratio 95% confidence interval 𝑝 value
Age 0.97 0.89 1.06 0.45
Gender
Female 1
Male 0.92 0.19 4.48 0.92
Mean arterial pressure 1.06 0.98 1.14 0.15
Body mass index 0.98 0.78 1.24 0.87
Triglyceride 1.001 0.998 1.003 0.57
HbA1C 0.78 0.39 1.54 0.47
Diabetic retinopathy
No diabetic retinopathy (𝑛 = 17) 1
Mild NPDR (𝑛 = 3) 3.03 0.43 21.45 0.27
Moderate NPDR (𝑛 = 0) — — — —
Severe NPDR (𝑛 = 0) — — — —
baPWV (cm/s)∗
baPWV ≤ 1378.9 (𝑛 = 4) 1
1378.9 < baPWV ≤ 1509 (𝑛 = 4) 0.69 0.07 6.75 0.75
1509 < baPWV ≤ 1706.3 (𝑛 = 5) 2.03 0.22 18.55 0.53
1706.3 < baPWV (𝑛 = 7) 1.99 0.17 22.83 0.58
∗
𝑝 for trend = 0.459.
significant difference between the two groups. After adjusting
for severity of diabetic retinopathy and HbA1C, baPWV was
independent risk factor of glaucoma. These results would
support the concept of arterial stiffness associated with glau-
coma independently from severity of diabetic retinopathy or
severity of DM.
Glaucoma may be associated with an alteration in factors
related to ocular blood flow and a breakdown of autoreg-
ulation [22]. In glaucoma patients with impaired vascular
autoregulation of ocular vessels, PP beyond critical range
can be hazardous to the ocular blood vessels and their
autoregulation [23–25]. In cases of impaired ocular vascular
autoregulation, ischemia and optic nerve damage can develop
due to low perfusion pressure caused by rising IOP and
low diastolic BP [26]. Grunwald et al. reported the presence
of decreased optic nerve blood flow in glaucoma patients.
In their study, patients with more advanced glaucomatous
damage in the visual field and cup-to-disc ratio tended
to exhibit worse optic nerve blood flow, suggesting that
decreased optic nerve blood flow might be associated with
progression of functional and morphologic glaucomatous
damage [23]. Michelson et al. suggested that POAG patients
showed significantly decreased optic nerve head blood flow
and juxtapapillary blood flow comparedwith an age-matched
control group [27]. However, this decreased juxtapapillary
blood flow was not significantly different between glaucoma
patients with and without treatment [27]. Schwartz found
that the circulatory defects in the optic disk and retina were
present in glaucoma and ocular hypertension subjects and
that these findings were correlated with glaucoma progres-
sion [28]. Several studies have shown an association between
the disturbance of systemic circulation and glaucoma [12–14].
Some studies have suggested the relationship between
systemic arteriosclerosis and retinal microvascular abnor-
malities. For example, hypertension has been associated with
retinal microvascular abnormalities including retinopathy,
focal arteriolar narrowing, and arteriovenous nicking [29].
After adjusting for age, gender, race, mean arterial blood
pressure, and antihypertensive medication use, retinopathy
was associated with prevalent coronary heart disease (OR,
1.7), prevalent myocardial infarction (OR, 1.7), prevalent
stroke (OR, 2.0), presence of carotid artery plaque (OR, 1.9),
increased intima-media thickness of the common carotid
(OR, 2.3; fourth versus first quartile), and internal carotid
(OR, 1.8; fourth versus first quartile) arteries [29]. Wong et al.
reported an association between retinal arteriolar narrowing
and risk of coronary heart disease [30]. Another study
suggested that a wider retinal venule was associated with
an increased relative risk of coronary heart disease-related
death [31]. In that study, a smaller arteriole to venule ratio
and narrower arterioles were significantly associated with
coronary heart disease-related death. Together, the associa-
tion of these retinal microvascular abnormalities to systemic
arteriosclerosis emphasizes that systemic arteriosclerosis can
alter the microvascular environment of the optic nerve head.
Relation between the systemic vascular function and
glaucoma also has been raised. Several studies reported
association of endothelial dysfunction and glaucoma. Su et al.
reported impaired endothelium-dependent flow-mediated
vasodilation in patients with NTG [32]. Another study
showed glaucoma patients have impaired endothelium-
dependent flow-mediated vasodilation and NTG patients
have lower endothelium-dependent flow-mediated vasodila-
tion than those with POAG [33].These results would support
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the concept of a systemic vascular dysfunction in OAG
patients, especially with NTG. And these results correspond
with this study results that faster baPWV in glaucoma
(especially in NTG) than control group.
The causes of the increased systemic arterial stiffness
may be because of the advanced glycation endproducts
(AGEs) and nitric oxide (NO) dysregulation in DM. Glucose
interacts with the free amino acid residues of proteins [34].
This initial reaction leads to the formation of intermediate
reversible Amadori products. The Amadori products change
to the irreversible AGEs ultimately. The AGE can deposit
on collagen the arterial wall and cause pathologic cross-
linking. AGE-mediated cross-links have a high resistance
to enzymatic proteolysis and a low degradation rate, which
may contribute to an increased collagen content in arterial
walls, characteristic of aging, and accelerated in DM [35].
NO has vasodilatory, antioxidant, antiplatelet, and anti-
inflammatory properties [36]. In the insulin-resistant state,
NO synthase activation is impaired and it may contribute
to endothelial dysfunction through interfering with NO-
mediated vasodilatation [37].
Increased systemic arterial stiffness may cause decreased
optic nerve blood flow and alter the vascular environ-
ment of the optic nerve, making it vulnerable to insult.
However, there are few studies on the association between
systemic arteriosclerosis and retinal circulation in patient
with glaucoma. In the Rotterdam Study, participants with
an increased PWV, indicative of high arterial stiffness, had
a higher prevalence of POAG, but the results were not
statistically significant (the ORs were adjusted for age, sex,
DM, cholesterol level, BMI, smoking, mean arterial BP, and
use of systemic antihypertensive medication; both definite
andprobable glaucoma caseswere included in the case group)
[26]. The progression of arteriosclerosis may result in blood
vessels with small lumens, increased resistance of peripheral
vessels, endothelial dysfunction, and decreased oxygenation.
It may cause an alteration in circulatory hemodynamics.
Since quantitative analysis of ocular arteriolosclerosis is
difficult, the relationship between ocular arteriolosclerosis
and local/systemic circulation has not been clearly defined.
In conclusion, DM patients with glaucoma showed a
higher brachial-ankle pulse wave velocity, which is generally
recognized as a marker of systemic arterial stiffness. Our
results suggest that systemic arterial stiffness may contribute
to the pathogenesis of glaucoma in DM patients. Thus, a
portion of DM patients who had high-grade systemic arterial
stiffness may be vulnerable to glaucoma.This is the first study
of the role of systemic arterial stiffness in glaucoma in DM
patients. However, this disruption of vascular autoregulation
may be correlated with various factors. Further studies are
needed to better understand the microcirculation which
affects the optic nerve head.
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